![Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2119035240/2088325543/ybbmt54827-fig-0001.jpg)
Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients | Haematologica
![Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram](https://www.researchgate.net/publication/282046248/figure/fig1/AS:499557352079360@1496115162692/Kaplan-Meier-curves-of-progression-free-survival-and-overall-survival-Progression-free.png)
Kaplan-Meier curves of progression-free survival and overall survival.... | Download Scientific Diagram
![PFS (A) and OS (B) comparing R-DA-EPOCH and R-CHOP regimen in 26 cases... | Download Scientific Diagram PFS (A) and OS (B) comparing R-DA-EPOCH and R-CHOP regimen in 26 cases... | Download Scientific Diagram](https://www.researchgate.net/publication/331018580/figure/fig3/AS:725115142668291@1549892330178/PFS-A-and-OS-B-comparing-R-DA-EPOCH-and-R-CHOP-regimen-in-26-cases-of-DHL-patients.png)
PFS (A) and OS (B) comparing R-DA-EPOCH and R-CHOP regimen in 26 cases... | Download Scientific Diagram
![Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0320-9/MediaObjects/41375_2018_320_Fig1_HTML.png)
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma | Leukemia
![Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas - The Lancet Oncology Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas - The Lancet Oncology](https://www.thelancet.com/cms/attachment/833f0a17-a9f5-4ef4-bba9-b5f3ef6e3b3b/gr2_lrg.jpg)
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas - The Lancet Oncology
![Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13000-019-0856-7/MediaObjects/13000_2019_856_Fig2_HTML.png)
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma | Diagnostic Pathology | Full Text
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
![Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12288-019-01248-w/MediaObjects/12288_2019_1248_Fig2_HTML.png)
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion
![Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12288-019-01248-w/MediaObjects/12288_2019_1248_Fig3_HTML.png)
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival | Indian Journal of Hematology and Blood Transfusion
![Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2119035701/2088332348/ybbmt54880-fig-0001.jpg)
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma - Biology of Blood and Marrow Transplantation
![Overall survival curve of patients with double-hit lymphoma (DHL) shows... | Download Scientific Diagram Overall survival curve of patients with double-hit lymphoma (DHL) shows... | Download Scientific Diagram](https://www.researchgate.net/publication/51976403/figure/fig4/AS:277254245502982@1443113971262/Overall-survival-curve-of-patients-with-double-hit-lymphoma-DHL-shows-inferior-survival.png)
Overall survival curve of patients with double-hit lymphoma (DHL) shows... | Download Scientific Diagram
![Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021 Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021](https://journals.sagepub.com/cms/10.1177/20406207211013987/asset/images/large/10.1177_20406207211013987-fig3.jpeg)
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications - Sotirios G. Papageorgiou, Thomas P. Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa, 2021
![Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5dd1c1030ee5cf96844d0c88cbb93e460d1e5540/3-Table1-1.png)
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation. | Semantic Scholar
![Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/be97aebbcd2be272d04201fac48ca772d19398c5/7-Figure2-1.png)
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas. | Semantic Scholar
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements | Haematologica
![Frontiers | Case report: Successful management of a refractory double- expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test Frontiers | Case report: Successful management of a refractory double- expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test](https://www.frontiersin.org/files/Articles/1079890/fonc-12-1079890-HTML/image_m/fonc-12-1079890-g001.jpg)
Frontiers | Case report: Successful management of a refractory double- expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test
![Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram Progression-free survival (PFS) curves (A) and overall survival (OS)... | Download Scientific Diagram](https://www.researchgate.net/publication/301288967/figure/fig2/AS:499556519342080@1496114963286/Progression-free-survival-PFS-curves-A-and-overall-survival-OS-curves-B-of-the.png)